BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9157588)

  • 1. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
    Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
    Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro.
    Mishima Y; Butt AL; Vandyck KB; Levy JH; Stewart KE; Tanaka KA
    Br J Anaesth; 2024 Jun; 132(6):1204-1210. PubMed ID: 38594117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.
    Xu Y; Cai C; Chandarajoti K; Hsieh PH; Li L; Pham TQ; Sparkenbaugh EM; Sheng J; Key NS; Pawlinski R; Harris EN; Linhardt RJ; Liu J
    Nat Chem Biol; 2014 Apr; 10(4):248-50. PubMed ID: 24561662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.
    Xu Y; Masuko S; Takieddin M; Xu H; Liu R; Jing J; Mousa SA; Linhardt RJ; Liu J
    Science; 2011 Oct; 334(6055):498-501. PubMed ID: 22034431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel method for measurement of heparin anticoagulant activity using SPR.
    Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
    Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
    Al-Horani RA; Liang A; Desai UR
    J Med Chem; 2011 Sep; 54(17):6125-38. PubMed ID: 21800826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct antithrombin activation modes for fondaparinux and natural heparins detected using millisecond hydrogen deuterium exchange and collision induced unfolding.
    Listigovers A; Lento C; Wilson DJ
    Int J Biol Macromol; 2024 Jun; ():132868. PubMed ID: 38838881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOW MOLECULAR WEIGHT HEPARINS.
    Sharma SK
    Med J Armed Forces India; 1998 Jul; 54(3):285-286. PubMed ID: 28775503
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions.
    Barrowcliffe TW; Le Shirley Y
    Thromb Haemost; 1989 Nov; 62(3):950-4. PubMed ID: 2556814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach to heparins.
    Hemker HC; Béguin S
    Nouv Rev Fr Hematol (1978); 1992; 34(1):5-9. PubMed ID: 1326098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.